Xolair is a branded injectable medication used to treat allergic asthma, chronic hives, and rhinosinusitis. It’s recently been approved to manage food allergies, reducing the risk of serious reactions ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new positive data from Stage 2 and Stage 3 of the National Institutes ...

The federally funded clinical trial is set to complete in 2026. The U.S. Food and Drug Administration has approved Xolair as the first and only medicine for people with one or more food allergies ...

ATLANTA - If you have to be vigilant about what you eat, and keep an EpiPen close, Dr. Tom Chacko of Chacko Allergy, Asthma and Sinus Center, says the newly FDA-authorized allergy medication, Xolair, ...

The Food and Drug Administration greenlighted a new drug on Friday that could be life-changing for those with severe food allergies. Xolair, or omalizumab, was approved to help reduce severe allergic ...

Please provide your email address to receive an email when new articles are posted on . The campaign follows the approval of Xolair for the reduction of allergic reactions after accidental exposure.

Thirty-six percent of patients treated with omalizumab were able to tolerate 2000mg of peanut protein and 2 other food allergens without experiencing an allergic reaction compared with 19% of ...

The star of the acquisition, anti-IgE antibody ozureprubart, is being tested as a prophylactic treatment for food allergies, ...

If you have food allergies, you know the dread: You'll be at a gathering and no one can tell you for sure if there are peanuts or eggs in any of the food. So you take a risk or you don't eat. Now, a ...

Please provide your email address to receive an email when new articles are posted on . 66% of patients remained treatment free for a year after halting treatment. 88.1% achieved equal or better ...

Chances are, you may know a family living with food allergies. Food allergies are more prevalent than many realize, particularly among children in the United States. In 2024, an estimated 3.4 million ...

– Results were featured as late-breakers at the 2025 AAAAI Annual Meeting – – Xolair is the only U.S. FDA-approved medicine to reduce allergic reactions in children and adults with one or more food ...